Implementation of a National Priority Allocation System for Hypersensitized Patients in Spain, Based on Virtual Crossmatch: Initial Results

Access to kidney transplantation for patients with high levels of antibodies against HLA is a major challenge. This issue makes it difficult to detect compatible donors for those patients in a certain geographical area. Consequently, hypersensitized patients remain on the waiting list for long periods and their quality of life deteriorates. Our purpose was to increase access to transplantation for highly sensitized patients by developing a national priority allocation system based on virtual crossmatch. Between June 15, 2015, and May 15, 2016, 675 patients on the kidney transplant waiting list with calculated panel-reactive antibodies ≥98% and undergoing dialysis for at least 12 months were included in the study; 86.1% of the patients had previously received at least one transplant. Solid-phase immunoassays were used to identify class I and II HLA antibodies in all patients. Participating hospitals assigned to the program one of the kidneys of every identified brain-dead real donor between 18 and 70 years old. Survival data were collected for the recipients transplanted between June 15, 2015, and December 31, 2015. In all, 475 (290 male and 185 female) brain-dead donors were assigned to the program. Virtual crossmatch was negative for 191 (41%) donors, 149 offers were accepted, and 102 (21.8%) kidneys were transplanted. At the end of the study, patient and graft survival were both 93.4%. The implementation of a national prioritization system based on virtual crossmatch increased access to transplantation for highly sensitized patients, with excellent results in terms of patient and graft survival.

Clinical validation of a real-time polymerase chain reaction assay for rapid detection of Acinetobacter baumannii colonization

Real-time polymerase chain reaction (PCR)-based approaches have not been assessed in terms of their ability to detect patients colonized by Acinetobacter baumannii during active surveillance. This prospective, double-blind study demonstrated that a real-time PCR assay had high sensitivity (100%) and specificity (91.2%) compared with conventional culture for detecting A. baumannii in 397 active surveillance samples, and provided results within 3h. Receiver-operator curve analyses demonstrated that the technique has diagnostic accuracy of 97.7% (95% confidence interval 96.0-99.3%). This method could facilitate the rapid implementation of infection control measures for preventing the transmission of A. baumannii.

Prevalence of schizophrenia and related disorders in Malaga (Spain): results using multiple clinical databases

BACKGROUND

To calculate the 1-year prevalence of schizophrenia and related disorders in a catchment area of Malaga (Spain) and determine the prevalence by gender, dwelling (rural or urban) and socioeconomic area (deprived or non-deprived area).

METHOD

This cross-sectional study comprised the mental health area covered by Carlos Haya Hospital. We used multiple large clinical databases and key informants to identify cases.

RESULTS

The mean 1-year prevalence of schizophrenia and related disorders was 6.27 per 1000. It was nearly double in men (8.45 per 1000) than in women (4.26 per 1000) (p < 0.001), with a male-to-female ratio of 1.98. The rate was higher in urban (6.64 per 1000) than rural areas (3.95 per 1000) (p < 0.0001) and in socioeconomic deprived areas (7.56 per 1000) than non-deprived areas (6.12 per 1000) (p = 0.005). For the subgroup of schizophrenia, the rates were: men, 5.88 per 1000 and women, 2.2 per 1000 (p < 0.0001), with a male-to-female ratio of 2.67. The rate was also higher in urban (4.2 per 1000) than rural areas (2.49 per 1000) (p < 0.0001) and in socioeconomic deprived areas (4.49 per 1000) than non-deprived areas (3.9 per 1000) (p = 0.149).

CONCLUSIONS

The use of multiple clinical sources of information not only from mental health services, but also from emergency departments, primary care and private settings revealed high prevalence rates of schizophrenia and related disorders. This diagnosis is more common in men and in cities. Such precise estimates of the prevalence of schizophrenia have important repercussions for resource allocation and policy planning.

Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses

BACKGROUND

Tecemotide is a MUC1-antigen-specific cancer immunotherapy. The phase III START study did not meet its primary end point but reported notable survival benefit with tecemotide versus placebo in an exploratory analysis of the predefined patient subgroup treated with concurrent chemoradiotherapy. Here, we attempted to gain further insight into the effects of tecemotide in START.

PATIENTS AND METHODS

START recruited patients who did not progress following frontline chemoradiotherapy for unresectable stage III non-small-cell lung cancer. We present updated overall survival (OS) data and exploratory analyses of OS for baseline biomarkers: soluble MUC1 (sMUC1), antinuclear antibodies (ANA), neutrophil/lymphocyte ratio (NLR), lymphocyte count, and HLA type.

RESULTS

Updated OS data are consistent with the primary analysis: median 25.8 months (tecemotide) versus 22.4 months (placebo) (HR 0.89, 95% CI 0.77-1.03, P = 0.111), with ∼20 months additional median follow-up time compared with the primary analysis. Exploratory analysis of the predefined subgroup treated with concurrent chemoradiotherapy revealed clinically relevant prolonged OS with tecemotide versus placebo (29.4 versus 20.8 months; HR 0.81, 95% CI 0.68-0.98, P = 0.026). No improvement was seen with sequential chemoradiotherapy. High sMUC1 and ANA correlated with a possible survival benefit with tecemotide (interaction P = 0.0085 and 0.0022) and might have future value as biomarkers. Interactions between lymphocyte count, NLR, or prespecified HLA alleles and treatment effect were not observed.

CONCLUSION

Updated OS data support potential treatment benefit with tecemotide in patients treated with concurrent chemoradiotherapy. Exploratory biomarker analyses suggest that elevated sMUC1 or ANA levels correlate with tecemotide benefit.

CLINICALTRIALSGOV NUMBER

NCT00409188.

[Characteristics of deep sedation in gastrointestinal endoscopic procedures performed by intensivists]

OBJECTIVE

To determine tolerance, pain intensity, percentage of tests completed successfully and complications of deep sedation controlled by intensivists during gastrointestinal endoscopic procedures.

DESIGN

A one-year, prospective observational study was carried out.

SETTING

Department of Intensive Care intervention in the Endoscopy Unit of Hospital Universitario del Tajo (Spain).

PATIENTS

Subjects over 15 years of age subjected to endoscopic procedures under deep sedation.

RESULTS

A total of 868 patients were sedated during the study period, with the conduction of 1010 endoscopic procedures. The degree of tolerance was considered adequate («Very good»/«Good») in 96.9% of the patients (95%CI: 95.7-98.1%), with a median score of 0 on the pain visual analog scale. A total of 988 endoscopic procedures were successfully completed (97.8%; 95%CI: 96.9-98.8%): 675 colonoscopies (97.1%) and 305 endoscopies (99.7%). Complications were recorded in 106 patients (12.2%; 95%CI: 10.0-14.5%). The most frequent being desaturation (6.1%), rhythm disturbances (5.1%) and hypotension (2.4%).

CONCLUSION

Gastrointestinal endoscopic procedures under sedation controlled by intensivists are well tolerated and satisfactory for the patient, and are successfully completed in a very large percentage of cases. The procedures are associated with frequent minor complications that are resolved successfully.

Easily accessible bifunctional Zn(salpyr) catalysts for the formation of organic carbonates

Alkylated Zn(salpyr) complexes (salpyr = N,N′-bis[salicylidene]-3,4-pyridinediamine) were prepared and used as catalyst precursors for the formation of cyclic carbonates from a range of (functional) epoxides and CO₂.

Patterns of visceral metastasis in cutaneous melanoma: a descriptive study

BACKGROUND AND OBJECTIVES

Some types of cancer tend to spread to certain organs. In the case of melanoma, uveal melanoma spreads almost exclusively to the liver, while cutaneous melanoma spreads to the liver and other organs. Although important advances have been made in our understanding of the molecular mechanisms underlying melanoma, few recent studies have focused on the patterns of visceral metastasis in cutaneous melanoma. The aim of this study was to retrospectively investigate whether clinicopathologic variants of cutaneous melanoma and primary tumor site might be associated with pattern and time of onset of metastasis to visceral sites, including the central nervous system (CNS).

MATERIALS AND METHODS

We included patients diagnosed with cutaneous melanoma between 1988 and 2009 with at least 2 years' follow-up.

RESULTS

Of the 1083 patients studied, 92 developed visceral metastasis. The CNS was affected in 21 cases, the lungs in 24, the liver in 17, the digestive tract in 7, and multiple organs simultaneously in 23. Metastasis to the lungs, the liver, and the digestive tract occurred within 5 years in most cases, while metastasis to the CNS and multiple organs occurred later (>5 years in 38% and 43% of cases, respectively).

CONCLUSIONS

Unlike uveal melanoma, cutaneous melanoma spreads to different organs without any particular predilection. We observed no significant associations between the site of visceral metastasis and either clinicopathologic variant or location of the primary tumor. Metastasis occurred within 5 years of diagnosis in most cases, but it can occur after 10 years.

Validity of insertion depth measurement in double-balloon endoscopy

BACKGROUND AND STUDY AIMS

In double-balloon enteroscopy (DBE) the use of a reliable and practical method to calculate the insertion depth of the endoscope could help to improve diagnosis accuracy and optimize the effort and cost of the technique. The objectives of this work were to compare and evaluate two methods of estimating the insertion depth and to obtain a descriptive model capable of representing the exploration dynamics and efficiency in terms of advanced distance and time.

METHODS

Oral DBE was performed in 25 pigs. Insertion depth was calculated during the procedure by: 1) estimation of time and distance for each push and pull cycle during progression; and 2) estimation of distance during withdrawal. At the maximum insertion depth a tattoo was placed, and the observed measures for the two methods were compared with the distance between the pylorus and the mark after euthanasia and necropsy of the animals 1 week after DBE.

RESULTS

The average insertion depth during progression, withdrawal, and after necropsy was 324.92 cm, 317.23 cm, and 342.05 cm, respectively (P Anova = 0.72). The Pearson correlation coefficient (r > 0.85; P < 0.001) and paired Brand - Altman plots demonstrated high agreement between progression and necropsy (0.03 % difference) and between withdrawal and necropsy (6.9 % difference). The exploration dynamics and efficiency in terms of advanced distance per cycle and time fitted to potential and logarithmic regression models, respectively.

CONCLUSIONS

Measurement of insertion depth in vivo was validated in the porcine model during progression and withdrawal. Estimation during progression was more accurate and allowed exploration dynamics and efficiency to be plotted, which might be used as approximate reference values for humans.

Notas nomenclaturales sobre anfibios actuales y fósiles

Una revisión de anfibios extintos y actuales en estado fósil (Allocaudata, Anura y Caudata) ha permitido detectar diversos casos que precisan cambios nomenclaturales a fin de estabilizar la taxonomía del grupo. Los cambios nomenclaturales incluyen homonimias, correcciones de variantes gramaticales y autorías, disponibilidad de nombres, y en especial la propuesta de nuevas combinaciones, necesarias para ajustar algunos taxones paleontológicos a los modelos de relaciones evolutivas entre formas vivientes, fundamentados en filogenias moleculares. Las nuevas combinaciones que se proponen son: Anaxyrus defensor para Bufo defensor Meylan, 2005; Anaxyrus hibbardi para Bufo hibbardi Taylor, 1937; Anaxyrus pliocompactilis para Bufo pliocompactilis Wilson, 1968; Anaxyrus repentinus para Bufo repentinus Tihen, 1962; Anaxyrus rexroadensis para Bufo rexroadensis Tihen, 1962; Anaxyrus spongifrons para Bufo spongifrons Tihen, 1962; Anaxyrus suspectus para Bufo suspectus Tihen, 1962; Anaxyrus tiheni para Bufo tiheni Auffenberg, 1957; Anaxyrus valentinensis para Bufo valentinensis Estes et Tihen, 1964; Ichthyosaura wintershofi para Triturus wintershofi Lunau, 1950; Incilius praevius para Bufo praevius Tihen, 1951; Lithobates bucella para Rana bucella Holman, 1965; Lithobates dubitus para Anchylorana dubita Taylor, 1942; Lithobates fayeae para Rana fayeae Taylor, 1942; Lithobates miocenicus para Rana miocenica Holman, 1965; Lithobates moorei para Anchylorana moorei Taylor, 1942; Lithobates parvissimus para Rana parvissima Taylor, 1942; Lithobates rexroadensis para Rana rexroadensis Taylor, 1942; Lithobates robustocondylus para Anchylorana robustocondyla Taylor, 1942; Ommatotriton roehrsi para Triturus roehrsi Herre, 1955; Pelophylax barani para Rana barani Rückert-Ülkumen, 1980; Pelophylax meriani para Rana meriani Meyer, 1853; Pelophylax pueyoi para Rana pueyoi Navás, 1922a; Pelophylax quellenbergi para Rana quellenbergi Navás, 1922; Philoria borealis para Kyarranus borealis Tyler, 1991; Pseudepidalea belogorica para Bufo belogoricus Ratnikov, 1993; Pseudepidalea plana para Bufo planus Ratnikov, 1993; Pseudepidalea prisca para Bufo priscus Spinar, Klembara et Meszáros, 1993, y Pseudepidalea stranensis para Bufo stranensis Nemec, 1972. Los nombres Geyeriellinae Brame, 1958, Palaeurodelidae Brame, 1958, Prosalamandridae Stefano, 1903, Lipelucidae Huene, 1956, Rana temporaria fossilis Stefanov, 1951, Salteniidae Kuhn, 1962, Vieraellidae Reig, 1961, y Voigtiellinae Brame, 1958 se consideran nomenclaturalmente no disponibles. El nombre de familia basado en Scapherpeton Cope, 1876 es Scapherpetidae y no Scapherpetonidae ni Scapherpetontidae.

[Experimental study with Doppler ultrasound in partial chronic obstructive uropathy]

INTRODUCTION

This study has aimed to assess the hemodynamic parameters, Renal Resistive Index (RI), Peak Systolic Velocity (PSV), End-Diastolic Velocity (EDV) and Blood Flow of the Renal Artery (FR) by Doppler Ultrasound for diagnosis and monitoring postsurgical partial chronic obstructive uropathy.

MATERIAL AND METHODS

Fifty pigs were used. The experiment was divided into three phases. Phase I consisted of a duplex-Doppler evaluation of the both kidneys to determine the parameters under study. The ratio of each index is calculated as the difference between the value of study kidney and the contralateral. After, a fluoroscopic examination was performed by compressive cystography, excretory urography and retrograde ureteropyelography. Finally, a model of partial right ureteral obstruction was created. After six weeks of the obstructive model, Phase II was begun with the diagnosis of the uropathy, by means of the aforementioned diagnostic methods and the endourological treatment was completed. Phase III is a follow-up performed at 6 months of treatment using the same methods as in the previous phases.

RESULTS

Of the parameters studied, the EDV and its ratio showed greater sensitivity and specificity as a diagnostic marker of obstructive uropathy. In the postoperative monitoring, it was observed that the RI and the EDV returned to baseline levels, with the baseline values.

CONCLUSIONS

The ΔEDV and its ratio is the parameter that shows the greater efficacy for the diagnosis of chronic partial obstructive uropathy, however, it is insufficient to avoid conventional diagnostic techniques. All the parameters, mainly the EDV, have proven useful as complementary tests for monitoring after endourologic resolution of obstructive uropathy.

Cerebrospinal fluid control of neurogenesis induced by retinoic acid during early brain development

Embryonic-cerebrospinal fluid (E-CSF) plays crucial roles in early brain development including the control of neurogenesis. Although FGF2 and lipoproteins present in the E-CSF have previously been shown to be involved in neurogenesis, the main factor triggering this process remains unknown. E-CSF contains all-trans-retinol and retinol-binding protein involved in the synthesis of retinoic acid (RA), a neurogenesis inducer. In early chick embryo brain, only the mesencephalic-rombencephalic isthmus (IsO) is able to synthesize RA. Here we show that in chick embryo brain development: (1) E-CSF helps to control RA synthesis in the IsO by means of the RBP and all-trans-retinol it contains; (2) E-CSF has retinoic acid activity, which suggests it may act as a diffusion pathway for RA; and (3) the influence of E-CSF on embryonic brain neurogenesis is to a large extent due to its involvement in RA synthesis. These data help to understand neurogenesis from neural progenitor cells.